These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37841365)

  • 61. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.
    Lei KC; Zhang XD
    Evol Med Public Health; 2020; 2020(1):290-303. PubMed ID: 33372198
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.
    de Souza AS; de Freitas Amorim VM; Guardia GDA; Dos Santos FF; Ulrich H; Galante PAF; de Souza RF; Guzzo CR
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.
    Huang JS; Huang JM; Zhang W
    Entropy (Basel); 2021 Apr; 23(5):. PubMed ID: 33922613
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 66. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis.
    McGrath ME; Xue Y; Dillen C; Oldfield L; Assad-Garcia N; Zaveri J; Singh N; Baracco L; Taylor LJ; Vashee S; Frieman MB
    Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2204717119. PubMed ID: 36040867
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.
    Molina-Mora JA; Cordero-Laurent E; Godínez A; Calderón-Osorno M; Brenes H; Soto-Garita C; Pérez-Corrales C; ; Drexler JF; Moreira-Soto A; Corrales-Aguilar E; Duarte-Martínez F
    Infect Genet Evol; 2021 Aug; 92():104872. PubMed ID: 33905892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
    Odongo S; Okella H; Ndekezi C; Okee M; Namayanja M; Mujuni B; Sterckx YGJ; Kizito D; Radwanska M; Magez S; Ikwap K; Mwiine FN; Lutwama JJ; Ibingira C
    PLoS One; 2022; 17(12):e0279428. PubMed ID: 36548384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics.
    Yesudhas D; Srivastava A; Gromiha MM
    Infection; 2021 Apr; 49(2):199-213. PubMed ID: 32886331
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants.
    Venkatakrishnan AJ; Anand P; Lenehan PJ; Ghosh P; Suratekar R; Silvert E; Pawlowski C; Siroha A; Chowdhury DR; O'Horo JC; Yao JD; Pritt BS; Norgan AP; Hurt RT; Badley AD; Halamka J; Soundararajan V
    Sci Rep; 2023 Jan; 13(1):257. PubMed ID: 36604461
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.
    Kumar A; Asghar A; Singh HN; Faiq MA; Kumar S; Narayan RK; Kumar G; Dwivedi P; Sahni C; Jha RK; Kulandhasamy M; Prasoon P; Sesham K; Kant K; Pandey SN
    JMIR Bioinform Biotechnol; 2023; 4():e42700. PubMed ID: 36688013
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Strain Variation Based on Spike Glycoprotein Gene of SARS-CoV-2 in Kuwait from 2020 to 2021.
    Madi N; Sadeq M; Essa S; Safar HA; Al-Adwani A; Al-Khabbaz M
    Pathogens; 2022 Aug; 11(9):. PubMed ID: 36145416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
    Laha S; Chakraborty J; Das S; Manna SK; Biswas S; Chatterjee R
    Infect Genet Evol; 2020 Nov; 85():104445. PubMed ID: 32615316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
    Mishra PM; Anjum F; Uversky VN; Nandi CK
    Biochem Biophys Res Commun; 2022 Sep; 620():8-14. PubMed ID: 35772213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.